HomeCDTX • NASDAQ
Cidara Therapeutics Inc
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.10M | 63.12% |
Net income | -83.23M | -420.69% |
Net profit margin | — | — |
Earnings per share | -3.10 | -30.25% |
EBITDA | -43.60M | -151.25% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 420.02M | 229.72% |
Total assets | 518.65M | 219.50% |
Total liabilities | 96.26M | 106.13% |
Total equity | 422.39M | — |
Shares outstanding | 31.44M | — |
Price to book | 15.17 | — |
Return on assets | -20.72% | — |
Return on capital | -23.51% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -83.23M | -420.69% |
Cash from operations | -40.62M | -10.68% |
Cash from investing | -176.47M | -166,381.13% |
Cash from financing | 160.00K | 187.91% |
Net change in cash | -216.93M | -486.55% |
Free cash flow | 37.81M | 223.17% |
Previous close
$218.41
Day range
$218.35 - $219.30
Year range
$15.02 - $219.30
Market cap
6.89B USD
Avg Volume
1.62M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2012
Headquarters
Website
Employees
38
